Search results
Results from the WOW.Com Content Network
On December 9, 2020, Health Canada approved the Pfizer–BioNTech COVID-19 vaccine.Vaccines were distributed amongst the provinces by the Federal government. [3] Ontario received an initial delivery of 6,000 doses of the Pfizer vaccine [4] of a total of 90,000 doses to be received before the end of 2020. [5]
Similarly to many anti-vaccination groups, Vaccine Choice Canada is opposing several measures instituted by public health authorities to limit the spread of the COVID-19 pandemic. Its President repeated some of the most widespread myths about the virus, including that it is no more dangerous than influenza and that developing a vaccine is ...
According to the U.S. Centers for Disease Control and Prevention, while "any vaccine can cause side effects", [11] most side effects are minor, primarily including sore arms or a mild fever. [11] Unlike most medical interventions vaccines are given to healthy people, where the risk of side effects is not as easily outweighed by the benefit of ...
For premium support please call: 800-290-4726 more ways to reach us
The Ontario government announced a COVID-19 vaccine certification system that came into effect on 22 September. [40] It was met with protests. [40] On October 28, 2021, Chief Medical Officer of Health of Ontario Kieran Moore said that Ontario will not integrate a COVID-19 vaccine requirement into the Immunization of School Pupils Act (ISPA) "at ...
The Immunization of School Pupils Act (ISPA) is a law in Ontario, Canada, that requires children and adolescents under the age of 18 to receive certain vaccinations to attend primary and secondary school unless a valid exemption is provided, which includes medical, religious, and conscience exemptions.
In Ontario, a Public Health Unit (PHU; French: Bureaux de santé) is a government organization under the supervision of a local board of health. A PHU is under the direction of a Medical Officer of Health (MOH), who is appointed by the supervising board of health.
Health Canada received a submission from Moderna on June 29, 2023, for yet another reformulated COVID-19 vaccine based on the Omicron XBB.1.5 subvariant of SARS-CoV-2. [131] The updated version was tested in a small human trial of 101 participants who had previously received four doses of previous formulations of the Moderna COVID-19 vaccine.